Persistent loss of taste and smell in patients with long COVID may respond to a novel approach – stellate ganglion block.Read More
While the idea of working from home may initially feel like a welcome break from clinical work, social distancing and telecommuting may not be easy for providers during a public health crisis like COVID-19. Physical therapist Mary Morrison, PT, DScPT, gives strategies on how to maintain healthy habits and productivity while working remotely.
COVID-19 symptoms appear more muted in pediatric patients than adults, according to a new study analyzes epidemiological characteristics of COVID-19 in children. Pediatric infectious disease expert Frank Esper, MD, discusses the implications and limitations of the study and how to advise parents about preventive measures.
Learn more about how COVID-19 causes ARDS, the histology of ARDS, and how diffuse alveolar damage causes hypoxia in this video.
Infectious disease outbreaks like COVID-19 can place considerable stress on caregivers, many of whom play a vital role in the delivery of care — and information — to patients and their families, and within their communities. The American Psychiatric Association published the following tips encouraging caregivers to prioritize their own health during this global health crisis.
Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services Policy
COVID-19 poses particular concerns for people being treated for neuroimmunologic disorders like multiple sclerosis. Our expert clinicians offer nuanced guidance on counseling patients about balancing risks and benefits.
In a public health crisis, caregivers and patients alike face ethical issues, including social restrictions, distribution of resources and privacy. In this Q&A, bioethicist Jane Jankowski, DPS, summarizes current and anticipated ethical dimensions of the COVID-19 pandemic.
Traditional methods of drug discovery cannot keep up with the rapid emergence and mutation of human coronavirus epidemics. Feixiong Cheng, PhD, has applied a network-based prediction model to identify targets for drug repurposing for the treatment of COVID-19.
Frank Esper, MD, pediatric infectious disease specialist, shares insight on COVID-19, discusses “old” and “new” coronaviruses and explores the impact of globalization on infectious diseases.